If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement 31 March 2016

24 May 2016 10:51

RNS Number : 1319Z
Mobeus Income & Growth VCT PLC
24 May 2016
 

 

Mobeus Income & Growth VCT plc ("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2016

 

Mobeus Income & Growth VCT plc reports an Interim Management Statement for the quarter ended 31 March 2016. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 March 2016

At 31 December 2015

 

Net assets attributable to shareholders

£74,634,178

 

£74,105,850

 

 

Shares in issue

75,972,951

75,972,951

 

 

Net asset value (NAV) per share

98.24p

97.54p

 

Cumulative dividends paid

 

74.30p

 

74.30p

 

 

Cumulative Total return (net asset value basis) per share since inception

 

172.54p

171.84p

 

% return on initial NAV per share of 94.5 pence at inception in July 2004

 

82.6 %

 

81.8 %

 

The net asset value per share has increased by 0.70 pence over the quarter, due mainly to income returns for the quarter and receipt of deferred consideration in respect of Focus Pharma, an investment realised in a prior year.

 

DIVIDENDS

A final dividend of 7.00 pence per share comprising 6.00 pence from capital and 1.00 penny from income in respect of the year ended 31 December 2015 was approved by shareholders at the Company's Annual General Meeting held at 2.00 pm today, and will be paid on 31 May 2016. This is in addition to the interim dividend of 3.00 pence per share (comprising 2.00 pence from capital and 1.00 penny from income) paid to shareholders on 17 September 2015. Payment of this final dividend will bring total dividends paid in respect of 2015 to 10.00 pence per share and cumulative dividends paid since inception to 81.30 pence per share. Payment of the 7.00 pence per share final dividend will reduce the NAV per share above to 91.24 pence.

 

UPDATE ON VCT LEGISLATION ("new VCT Rules")

As noted in the Company's recent Annual Report, the new VCT Rules included measures that will change significantly the size and type of investments the Company can make. The Company is no longer permitted to fund MBO investments, but has changed focus to provide growth and development capital to younger, earlier stage companies. Further HMRC guidance on the detailed application of the new VCT Rules has been published recently, which the Investment Adviser is currently reviewing.

 

NEW INVESTMENT

In February 2016, one of the VCT's companies preparing to trade invested £1.09 million into Redline Assured Security Limited, a market leader in the provision of security consultancy and training services to airlines, airports, governments and global distribution companies.

 

This is the first new investment made by the Company in compliance with the new VCT Rules.

 

NEW INVESTMENT POLICY

Shareholders also approved the Company's new Investment Policy at today's AGM. The new Policy was prepared in response to the new VCT Rules and enables the Company to continue making investments that comply with them.

 

DIVESTMENTS

There were no realisations in the period. However, £0.03 million was received from Newquay Helicopters as an interim distribution resulting from a members' voluntary liquidation of the Company. Further consideration of £0.60 million was received in respect of Focus Pharma, an investment realised in 2014.

 

LOAN STOCK REPAYMENTS

The VCT received £1.10 million of loan repayments in the quarter, £1.00 million of which was a final loan stock repayment from Leap New Co Limited (trading as Ward Thomas Removals, Bishopsgate and Aussie Man & Van).

 

In April 2016, the VCT received further loan repayments from Jablite of £0.08 million.

 

SHARE BUYBACKS

The Company did not conduct any share buybacks during the period. Following the period end in April 2016, the Company bought back 275,000 of its own shares at a price of 86 pence per share. The buyback represented 0.4% of the issued share capital at the beginning of the year.

 

For further information, please contact:

Sarah Penfold, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7615.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGZKLDKGVZG
Date   Source Headline
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20231:30 pmRNSInterim Management Statement
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
21st Sep 202310:15 amRNSDividend Declaration
18th Sep 20231:00 pmRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 202310:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
4th Apr 20236:07 pmRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20236:20 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:06 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
17th Jan 20235:16 pmRNSDirector Declaration
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
5th Dec 20225:49 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 20228:34 amRNSTransaction in Own Shares and total voting rights
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20225:41 pmRNSIssue of Equity and Total Voting Rights
9th Nov 20223:40 pmRNSNet Asset Value(s)
9th Nov 20223:00 pmRNSInterim Management Statement
17th Oct 20221:52 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:05 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
5th Sep 20224:20 pmRNSHalf-year Report
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
13th Jun 20222:00 pmRNSRealisation of investment - Media Business Insight

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.